[Federal Register Volume 76, Number 33 (Thursday, February 17, 2011)]
[Notices]
[Pages 9353-9354]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2011-3631]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Quantitative Imaging for Evaluation of Responses to Cancer
Therapies.
Date: March 2, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Gerald G. Lovinger, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Blvd., Room 8101, Bethesda, MD 20892-8329, 301/496-7987,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; The Role of Microbial Metabolites in Cancer Prevention and
Etiology.
Date: March 7, 2011.
Time: 8 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Gerald G. Lovinger, PhD, Scientific Review
Administrator, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Blvd., Room 8101, Bethesda, MD 20892-8329, 301/496-7987,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Quantitative Imaging for Tumor Microenvironment.
Date: March 9, 2011.
Time: 8 a.m. to 10 a.m.
Agenda: To review and evaluate contract proposals.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Zhiqiang Zou, MD, PhD, Scientific Review
Officer, National Cancer Institute, National Institutes of Health,
6116 Executive Blvd., Room 8055A, Bethesda, MD 20852,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Development of Image Processing and Analysis Software for
Oncology.
Date: March 9, 2011.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Zhiqiang Zou, MD, PhD, Scientific Review
Officer, National Cancer Institute, National Institutes of Health,
6116 Executive Blvd., Room 8055A, Bethesda, MD 20852,
[email protected].
[[Page 9354]]
Name of Committee: National Cancer Institute Special Emphasis
Panel; Collaborative Practices in Palliative and Hospice Care.
Date: March 14, 2011.
Time: 3 p.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 8055B, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Ellen K Schwartz, PhD, Scientific Review
Officer, Special Review & Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 8055B, Bethesda, MD 20892-8329, 301-594-1215,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Molecular Pharmacodynamic Assays.
Date: March 15, 2011.
Time: 8 a.m. to 12 p.m.
Agenda: To review and evaluate contract proposals.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Adriana Stoica, PhD, Scientific Review Officer,
Special Review & Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd.,
Ste 703, Rm 7072, Bethesda, MD 20892-8329, 301-594-1408,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Companion Diagnostics.
Date: March 15-16, 2011.
Time: 12 p.m. to 6 p.m.
Agenda: To review and evaluate contract proposals.
Place: Legacy Hotel and Meeting Center, 1775 Rockville Pike,
Rockville, MD 20852.
Contact Person: Adriana Stoica, PhD, Scientific Review Officer,
Special Review & Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive Blvd.,
Ste 703, Rm 7072, Bethesda, MD 20892-8329, 301-594-1408,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Prostate Imaging Meeting.
Date: March 22, 2011.
Time: 1 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 8103, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Timothy C. Meeker, M.D., PhD, Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8103, Bethesda, MD 20892, (301) 594-1279,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Biomarker Resources.
Date: March 23, 2011.
Time: 1:30 p.m. to 3 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 707, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Zhiqiang Zou, M.D., PhD, Scientific Review
Officer, National Cancer Institute, National Institutes of Health,
6116 Executive Blvd., Room 8055A, Bethesda, MD 20852,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Exceptional, Unconventional, Research Enabling Knowledge
Acceleration (EUREKA).
Date: March 28-29, 2011.
Time: 8 a.m. to 6 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott & Conference Ctr, 5701 Marinelli
Road, Bethesda, MD 20852.
Contact Person: Clifford W. Schweinfest, PhD, Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, 6116 Executive Blvd., Room
8050a, Bethesda, MD 20892-8329, 301-402-9415,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Manufacturing Therapeutic Biologics Meeting.
Date: March 28, 2011.
Time: 12 p.m. to 4 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institutes of Health, 6116 Executive Boulevard,
Room 8103, Rockville, MD 20852 (Telephone Conference Call).
Contact Person: Timothy C. Meeker, M.D., PhD, Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, 6116 Executive
Boulevard, Room 8103, Bethesda, MD 20892, (301) 594-1279,
[email protected].
Name of Committee: National Cancer Institute Special Emphasis
Panel; Small Grant for Behavioral Research in Cancer Control (R03).
Date: March 31-April 1, 2011.
Time: 8:30 a.m. to 5 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Ellen K. Schwartz, PhD, Scientific Review
Officer, Special Review & Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 6116 Executive
Boulevard, Room 8055B, Bethesda, MD 20892-8329, 301-594-1215,
[email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 10, 2011.
Jennifer S. Spaeth,
Director, Office of Federal Advisory Committee Policy.
[FR Doc. 2011-3631 Filed 2-16-11; 8:45 am]
BILLING CODE 4140-01-P